{
    "Symbol": "ALPA",
    "ISIN": "INE385I01010",
    "News": [
        {
            "Title": "Alpa Labs Q3FY26 Results: Revenue Up 13.5% YoY",
            "Summary": "Alpa Laboratories reported Q3FY26 revenue of Rs 2,967.12 lacs vs Rs 2,615.02 lacs YoY. Net profit declined to Rs 187.48 lacs from Rs 889.30 lacs in Q3FY25.",
            "Sentiment": "neutral",
            "PublishDate": 1770795487888,
            "Source": "co_actions_results"
        },
        {
            "Title": "Alpa Laboratories Reports Strong Q1 Results with 1,177.59 Lakh Profit and Approves 37th AGM Notice",
            "Summary": "Alpa Laboratories Ltd. approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, and the notice for its 37th Annual General Meeting. The company reported standalone revenue from operations of 1,911.07 lakh compared to 2,144.37 lakh in the same quarter last year. Standalone profit for the quarter was 1,177.59 lakh, significantly higher than 512.45 lakh in June 2024. Other income increased substantially to 1,195.78 lakh from 516.02 lakh year-over-year, which included unrealized profit from fair market value increases in investments. On a consolidated basis, the company reported similar performance with profit of 1,176.78 lakh versus 509.63 lakh in the previous year quarter. The company operates in the single segment of Drugs & Chemicals. The results were reviewed by the Audit Committee and received an unmodified review conclusion from statutory auditors.",
            "Sentiment": "positive",
            "PublishDate": 1755100139982,
            "Source": "earnings"
        }
    ]
}